Rocket Lab USA (NASDAQ: RKLB) trades at $73.61, well below the consensus Wall Street price target of $109.37, implying roughly 49% upside from current levels.
Pierre Ferragu of New Street Research holds the Street-high 12-month price target of $150, which would nearly double the stock from where it currently sits.
The $150 target sits above a broader analyst target range of $64 to $150, with the median hovering near $110, making New Street’s call a significant outlier in the coverage universe.
Rocket Lab is the second-most-recognized name in Western launch behind SpaceX, operating the Electron small-lift rocket and building out a growing Space Systems business alongside the forthcoming medium-lift Neutron rocket.
The company carries a $2.36 billion backlog, a pending acquisition of Iridium Communications, and an expanding U.S. defense book that has made it a consistent favorite among space-sector investors.
RKLB shares have fallen more than 51% from their 52-week high of $151, and the stock is down 8.77% over the trailing three months, sliding from $80.69 even as broader market indexes advanced.
Neutron is at the center of the bull-versus-bear debate, with management indicating the window for an end-of-year launch is narrowing after a stage-1 tank test failure earlier this year.
Dilution has added pressure on top of the Neutron uncertainty, with Rocket Lab pulling $1.08 billion through its ATM program in Q2 and Q3 guidance calling for roughly 641 million basic weighted shares outstanding.
The Q2 non-GAAP free-cash-flow use of $110.1 million and a price-to-sales ratio of 58 gave profit-takers additional reason to trim positions heading into the second half of 2026.
The bull thesis rests on Neutron commercialization at $50 to $55 million per flight, expanding government contract wins including a $397 million Flatellite award for the Space Force SB-AMTI program, and vertical integration through the Iridium deal.
Iridium serves more than 2.5 million subscribers and generated over $870 million in annual revenue last year, giving the combined entity a meaningful and recurring revenue base alongside the launch business.
Of 18 analysts covering RKLB, 3 rate it Strong Buy, 11 Buy, 4 Hold, and none carry a Sell rating, reflecting broad if cautiously calibrated optimism across the Street.
Q3 revenue guidance of $250 million to $265 million, more than $1 billion in new Q3 contracts already signed, and a backlog that grew 137% year-over-year give the bulls concrete metrics to point toward.
Among space-sector peers, Intuitive Machines (NASDAQ: LUNR) shows the largest consensus-implied upside at 88%, while AST SpaceMobile (NASDAQ: ASTS) implies 30% and Redwire (NYSE: RDW) implies roughly 27%.
Rocket Lab remains the only name in the peer group where a mainstream research shop publicly models a full double, distinguishing RKLB as the higher-conviction bull case in the space complex.
RKLB is up 5.52% year to date versus a 12.52% gain for the S&P 500, though the stock has rebounded 10.01% over the past month and 8.54% over the past week.
Rocket Lab’s beta of 2.6 signals that the path to either the bull or bear scenario will be volatile and unlikely to move in a straight line for patient investors.
The bear case materializes if Neutron slips into 2027, dilution continues to erode per-share value, or integration of the Iridium acquisition proves more complicated than management currently projects.
No other Western pure-play currently combines launch capability, spacecraft manufacturing, and a global communications constellation in the way Rocket Lab’s strategy envisions, which is the core differentiation the bulls are pricing in.
At roughly half the Street-high target and 49% below consensus, the risk/reward equation tilts constructive for investors who can tolerate the stock’s considerable beta and execution uncertainty.
